MIRA Reports Preclinical Data
MIRA Pharmaceuticals reports new preclinical data demonstrating Mira-55's differentiated mechanism of action and anxiolytic activity relative to THC
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.